Mylan NV CEO Heather Bresch faced tough questioning Wednesday from Republicans and Democrats in Congress probing price increases for the EpiPen allergy treatment.
WSJ.com: What's News US, Wall Street Journal
Wed, 09/21/2016 - 6:57pm
Mylan NV CEO Heather Bresch faced tough questioning Wednesday from Republicans and Democrats in Congress probing price increases for the EpiPen allergy treatment.